Artificial Coma/Medically Induced Coma Market Research Report: Information By Type (Propofol and Barbiturate), By Application (Status Epilepticus, Stroke, Traumatic Brain Injury, Brain Infections, Drug Overdose, and Others), By Distribution Channel (Hospital Pharmacies and Drug Stores & Retail Pharmacies), And By Region (North America, Europe, Asia-Pacific, And Rest Of The World) –Market Forecast Till 2032.

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET INTRODUCTION

2.1. Definition

2.2. Scope of the Study

2.2.1. Research Objective

2.2.2. Assumptions

2.2.3. Limitations

3. RESEARCH METHODOLOGY

3.1. Overview

3.2. Data Mining

3.3. Secondary Research

3.4. Primary Research

3.4.1. Primary Interviews and Information Gathering Process

3.4.2. Breakdown of Primary Respondents

3.5. Forecasting Model

3.6. Market Size Estimation

3.6.1. Bottom-Up Approach

3.6.2. Top-Down Approach

3.7. Data Triangulation

3.8. Validation

4. MARKET DYNAMICS

4.1. Overview

4.2. Drivers

4.3. Restraints

4.4. Opportunities

5. MARKET FACTOR ANALYSIS

5.1. Value Chain Analysis

5.2. Porter’s Five Forces Analysis

5.2.1. Bargaining Power of Suppliers

5.2.2. Bargaining Power of Buyers

5.2.3. Threat of New Entrants

5.2.4. Threat of Substitutes

5.2.5. Intensity of Rivalry

5.3. COVID-19 Impact Analysis

5.3.1. Market Impact Analysis

5.3.2. Regional Impact

5.3.3. Opportunity and Threat Analysis

6. GLOBAL ARTIFICIAL COMA / MEDICALLY INDUCED COMA MARKET, BY TYPE

6.1. Overview

6.2. Propofol

6.3. Barbiturate

7. GLOBAL ARTIFICIAL COMA / MEDICALLY INDUCED COMA MARKET, BY APPLICATION

7.1. Overview

7.2. Status Epilepticus

7.3. Stroke

7.4. Traumatic Brain Injury

7.5. Brain Infections

7.6. Drug Overdose

7.7. Others

8. GLOBAL ARTIFICIAL COMA / MEDICALLY INDUCED COMA MARKET, BY DISTRIBUTION CHANNEL

8.1. Overview

8.2. Hospital Pharmacies

8.3. Drug Stores & Retail Pharmacies

9. GLOBAL ARTIFICIAL COMA / MEDICALLY INDUCED COMA MARKET, BY REGION

9.1. Overview

9.1. North America

9.1.1. US

9.1.2. Canada

9.2. Europe

9.2.1. Germany

9.2.2. France

9.2.3. UK

9.2.4. Italy

9.2.5. Spain

9.2.6. Rest of Europe

9.3. Asia-Pacific

9.3.1. China

9.3.2. India

9.3.3. Japan

9.3.4. South Korea

9.3.5. Australia

9.3.6. Rest of Asia-Pacific

9.4. Rest of the World

9.4.1. Middle East

9.4.2. Africa

9.4.3. Latin America

10. COMPETITIVE LANDSCAPE

10.1. Overview

10.2. Competitive Analysis

10.3. Market Share Analysis

10.4. Major Growth Strategy in the Global Artificial coma / medically induced coma Market,

10.5. Competitive Benchmarking

10.6. Leading Players in Terms of Number of Developments in the Global Artificial coma / medically induced coma Market,

10.7. Key developments and Growth Strategies

10.7.1. New Product Launch/Service Deployment

10.7.2. Merger & Acquisitions

10.7.3. Joint Ventures

10.8. Major Players Financial Matrix

10.8.1. Sales & Operating Income, 2022

10.8.2. Major Players R&D Expenditure. 2022

11. COMPANY PROFILES

11.1. PIRAMAL GROUP

11.1.1. Company Overview

11.1.2. Financial Overview

11.1.3. Products Offered

11.1.4. Key Developments

11.1.5. SWOT Analysis

11.1.6. Key Strategies

11.2. TEVA PHARMACEUTICAL INDUSTRIES LTD.

11.2.1. Company Overview

11.2.2. Financial Overview

11.2.3. Products Offered

11.2.4. Key Developments

11.2.5. SWOT Analysis

11.2.6. Key Strategies

11.3. HIKMA PHARMACEUTICALS

11.3.1. Company Overview

11.3.2. Financial Overview

11.3.3. Products Offered

11.3.4. Key Developments

11.3.5. SWOT Analysis

11.3.6. Key Strategies

11.4. FRESENIUS SE & CO KGAA

11.4.1. Company Overview

11.4.2. Financial Overview

11.4.3. Products Offered

11.4.4. Key Developments

11.4.5. SWOT Analysis

11.4.6. Key Strategies

11.5. ASTRAZENECA PLC

11.5.1. Company Overview

11.5.2. Financial Overview

11.5.3. Products Offered

11.5.4. Key Developments

11.5.5. SWOT Analysis

11.5.6. Key Strategies

11.6. DR. REDDY’S LABORATORY

11.6.1. Company Overview

11.6.2. Financial Overview

11.6.3. Products Offered

11.6.4. Key Developments

11.6.5. SWOT Analysis

11.6.6. Key Strategies

11.7. PFIZER INC.

11.7.1. Company Overview

11.7.2. Financial Overview

11.7.3. Products Offered

11.7.4. Key Developments

11.7.5. SWOT Analysis

11.7.6. Key Strategies

11.8. VIATRIS INC. (MYLAN N.V)

11.8.1. Company Overview

11.8.2. Financial Overview

11.8.3. Products Offered

11.8.4. Key Developments

11.8.5. SWOT Analysis

11.8.6. Key Strategies

11.9. B.BRAUN MELSUNGEN AG

11.9.1. Company Overview

11.9.2. Financial Overview

11.9.3. Products Offered

11.9.4. Key Developments

11.9.5. SWOT Analysis

11.9.6. Key Strategies

11.10. BAXTER INTERNATIONAL INC.

11.10.1. Company Overview

11.10.2. Financial Overview

11.10.3. Products Offered

11.10.4. Key Developments

11.10.5. SWOT Analysis

11.10.6. Key Strategies

12. APPENDIX

12.1. References

12.2. Related Reports

LIST OF TABLES

TABLE 1 GLOBAL ARTIFICIAL COMA / MEDICALLY INDUCED COMA MARKET, SYNOPSIS, 2018-2032

TABLE 2 GLOBAL ARTIFICIAL COMA / MEDICALLY INDUCED COMA MARKET, ESTIMATES & FORECAST, 2018-2032 (USD BILLION)

TABLE 3 GLOBAL ARTIFICIAL COMA / MEDICALLY INDUCED COMA MARKET, BY TYPE, 2018-2032 (USD BILLION)

TABLE 4 GLOBAL ARTIFICIAL COMA / MEDICALLY INDUCED COMA MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 5 GLOBAL ARTIFICIAL COMA / MEDICALLY INDUCED COMA MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)

TABLE 6 NORTH AMERICA: ARTIFICIAL COMA / MEDICALLY INDUCED COMA MARKET, BY TYPE, 2018-2032 (USD BILLION)

TABLE 7 NORTH AMERICA: ARTIFICIAL COMA / MEDICALLY INDUCED COMA MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 8 NORTH AMERICA: ARTIFICIAL COMA / MEDICALLY INDUCED COMA MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)

TABLE 9 US: ARTIFICIAL COMA / MEDICALLY INDUCED COMA MARKET, BY TYPE, 2018-2032 (USD BILLION)

TABLE 10 US: ARTIFICIAL COMA / MEDICALLY INDUCED COMA MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 11 US: ARTIFICIAL COMA / MEDICALLY INDUCED COMA MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)

TABLE 12 CANADA: ARTIFICIAL COMA / MEDICALLY INDUCED COMA MARKET, BY TYPE, 2018-2032 (USD BILLION)

TABLE 13 CANADA: ARTIFICIAL COMA / MEDICALLY INDUCED COMA MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 14 CANADA: ARTIFICIAL COMA / MEDICALLY INDUCED COMA MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)

TABLE 15 EUROPE: ARTIFICIAL COMA / MEDICALLY INDUCED COMA MARKET, BY TYPE, 2018-2032 (USD BILLION)

TABLE 16 EUROPE: ARTIFICIAL COMA / MEDICALLY INDUCED COMA MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 17 EUROPE: ARTIFICIAL COMA / MEDICALLY INDUCED COMA MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)

TABLE 18 GERMANY: ARTIFICIAL COMA / MEDICALLY INDUCED COMA MARKET, BY TYPE, 2018-2032 (USD BILLION)

TABLE 19 GERMANY: ARTIFICIAL COMA / MEDICALLY INDUCED COMA MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 20 GERMANY: ARTIFICIAL COMA / MEDICALLY INDUCED COMA MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)

TABLE 21 FRANCE: ARTIFICIAL COMA / MEDICALLY INDUCED COMA MARKET, BY TYPE, 2018-2032 (USD BILLION)

TABLE 22 FRANCE: ARTIFICIAL COMA / MEDICALLY INDUCED COMA MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 23 FRANCE: ARTIFICIAL COMA / MEDICALLY INDUCED COMA MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)

TABLE 24 ITALY: ARTIFICIAL COMA / MEDICALLY INDUCED COMA MARKET, BY TYPE, 2018-2032 (USD BILLION)

TABLE 25 ITALY: ARTIFICIAL COMA / MEDICALLY INDUCED COMA MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 26 ITALY: ARTIFICIAL COMA / MEDICALLY INDUCED COMA MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)

TABLE 27 SPAIN: ARTIFICIAL COMA / MEDICALLY INDUCED COMA MARKET, BY TYPE, 2018-2032 (USD BILLION)

TABLE 28 SPAIN: ARTIFICIAL COMA / MEDICALLY INDUCED COMA MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 29 SPAIN: ARTIFICIAL COMA / MEDICALLY INDUCED COMA MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)

TABLE 30 UK: ARTIFICIAL COMA / MEDICALLY INDUCED COMA MARKET, BY TYPE, 2018-2032 (USD BILLION)

TABLE 31 UK: ARTIFICIAL COMA / MEDICALLY INDUCED COMA MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 32 UK: ARTIFICIAL COMA / MEDICALLY INDUCED COMA MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)

TABLE 33 REST OF EUROPE: ARTIFICIAL COMA / MEDICALLY INDUCED COMA MARKET, BY TYPE, 2018-2032 (USD BILLION)

TABLE 34 REST OF EUROPE: ARTIFICIAL COMA / MEDICALLY INDUCED COMA MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 35 REST OF EUROPE: ARTIFICIAL COMA / MEDICALLY INDUCED COMA MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)

TABLE 36 ASIA-PACIFIC: ARTIFICIAL COMA / MEDICALLY INDUCED COMA MARKET, BY TYPE, 2018-2032 (USD BILLION)

TABLE 37 ASIA-PACIFIC: ARTIFICIAL COMA / MEDICALLY INDUCED COMA MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 38 ASIA-PACIFIC: ARTIFICIAL COMA / MEDICALLY INDUCED COMA MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)

TABLE 39 JAPAN: ARTIFICIAL COMA / MEDICALLY INDUCED COMA MARKET, BY TYPE, 2018-2032 (USD BILLION)

TABLE 40 JAPAN: ARTIFICIAL COMA / MEDICALLY INDUCED COMA MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 41 JAPAN: ARTIFICIAL COMA / MEDICALLY INDUCED COMA MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)

TABLE 42 CHINA: ARTIFICIAL COMA / MEDICALLY INDUCED COMA MARKET, BY TYPE, 2018-2032 (USD BILLION)

TABLE 43 CHINA: ARTIFICIAL COMA / MEDICALLY INDUCED COMA MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 44 CHINA: ARTIFICIAL COMA / MEDICALLY INDUCED COMA MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)

TABLE 45 INDIA: ARTIFICIAL COMA / MEDICALLY INDUCED COMA MARKET, BY TYPE, 2018-2032 (USD BILLION)

TABLE 46 INDIA: ARTIFICIAL COMA / MEDICALLY INDUCED COMA MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 47 INDIA: ARTIFICIAL COMA / MEDICALLY INDUCED COMA MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)

TABLE 48 AUSTRALIA: ARTIFICIAL COMA / MEDICALLY INDUCED COMA MARKET, BY TYPE, 2018-2032 (USD BILLION)

TABLE 49 AUSTRALIA: ARTIFICIAL COMA / MEDICALLY INDUCED COMA MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 50 AUSTRALIA: ARTIFICIAL COMA / MEDICALLY INDUCED COMA MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)

TABLE 51 SOUTH KOREA: ARTIFICIAL COMA / MEDICALLY INDUCED COMA MARKET, BY TYPE, 2018-2032 (USD BILLION)

TABLE 52 SOUTH KOREA: ARTIFICIAL COMA / MEDICALLY INDUCED COMA MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 53 SOUTH KOREA: ARTIFICIAL COMA / MEDICALLY INDUCED COMA MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)

TABLE 54 REST OF ASIA-PACIFIC: ARTIFICIAL COMA / MEDICALLY INDUCED COMA MARKET, BY TYPE, 2018-2032 (USD BILLION)

TABLE 55 REST OF ASIA-PACIFIC: ARTIFICIAL COMA / MEDICALLY INDUCED COMA MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 56 REST OF ASIA-PACIFIC: ARTIFICIAL COMA / MEDICALLY INDUCED COMA MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)

TABLE 57 REST OF THE WORLD: ARTIFICIAL COMA / MEDICALLY INDUCED COMA MARKET, BY TYPE, 2018-2032 (USD BILLION)

TABLE 58 REST OF THE WORLD: ARTIFICIAL COMA / MEDICALLY INDUCED COMA MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 59 REST OF THE WORLD: ARTIFICIAL COMA / MEDICALLY INDUCED COMA MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)

TABLE 60 MIDDLE EAST: ARTIFICIAL COMA / MEDICALLY INDUCED COMA MARKET, BY TYPE, 2018-2032 (USD BILLION)

TABLE 61 MIDDLE EAST: ARTIFICIAL COMA / MEDICALLY INDUCED COMA MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 62 MIDDLE EAST: ARTIFICIAL COMA / MEDICALLY INDUCED COMA MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)

TABLE 63 AFRICA: ARTIFICIAL COMA / MEDICALLY INDUCED COMA MARKET, BY TYPE, 2018-2032 (USD BILLION)

TABLE 64 AFRICA: ARTIFICIAL COMA / MEDICALLY INDUCED COMA MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 65 AFRICA: ARTIFICIAL COMA / MEDICALLY INDUCED COMA MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)

TABLE 66 LATIN AMERICA: ARTIFICIAL COMA / MEDICALLY INDUCED COMA MARKET, BY TYPE, 2018-2032 (USD BILLION)

TABLE 67 LATIN AMERICA: ARTIFICIAL COMA / MEDICALLY INDUCED COMA MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 68 LATIN AMERICA: ARTIFICIAL COMA / MEDICALLY INDUCED COMA MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)

LIST OF FIGURES

FIGURE 1 RESEARCH PROCESS

FIGURE 2 MARKET STRUCTURE FOR THE GLOBAL ARTIFICIAL COMA / MEDICALLY INDUCED COMA MARKET

FIGURE 3 MARKET DYNAMICS FOR THE GLOBAL ARTIFICIAL COMA / MEDICALLY INDUCED COMA MARKET

FIGURE 4 GLOBAL ARTIFICIAL COMA / MEDICALLY INDUCED COMA MARKET, SHARE (%), BY TYPE, 2022

FIGURE 5 GLOBAL ARTIFICIAL COMA / MEDICALLY INDUCED COMA MARKET, SHARE (%), BY APPLICATION, 2022

FIGURE 6 GLOBAL ARTIFICIAL COMA / MEDICALLY INDUCED COMA MARKET, SHARE (%), BY DISTRIBUTION CHANNEL, 2022

FIGURE 7 GLOBAL ARTIFICIAL COMA / MEDICALLY INDUCED COMA MARKET, SHARE (%), BY REGION, 2022

FIGURE 8 NORTH AMERICA: ARTIFICIAL COMA / MEDICALLY INDUCED COMA MARKET, SHARE (%), BY REGION, 2022

FIGURE 9 EUROPE: ARTIFICIAL COMA / MEDICALLY INDUCED COMA MARKET, SHARE (%), BY REGION, 2022

FIGURE 10 ASIA-PACIFIC: ARTIFICIAL COMA / MEDICALLY INDUCED COMA MARKET, SHARE (%), BY REGION, 2022

FIGURE 11 REST OF THE WORLD: ARTIFICIAL COMA / MEDICALLY INDUCED COMA MARKET, SHARE (%), BY REGION, 2022

FIGURE 12 GLOBAL ARTIFICIAL COMA / MEDICALLY INDUCED COMA MARKET: COMPANY SHARE ANALYSIS, 2022 (%)

FIGURE 13 PIRAMAL GROUP: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 14 PIRAMAL GROUP: SWOT ANALYSIS

FIGURE 15 TEVA PHARMACEUTICAL INDUSTRIES LTD.: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 16 TEVA PHARMACEUTICAL INDUSTRIES LTD.: SWOT ANALYSIS

FIGURE 17 HIKMA PHARMACEUTICALS: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 18 HIKMA PHARMACEUTICALS: SWOT ANALYSIS

FIGURE 19 FRESENIUS SE & CO KGAA: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 20 FRESENIUS SE & CO KGAA: SWOT ANALYSIS

FIGURE 21 ASTRAZENECA PLC.: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 22 ASTRAZENECA PLC.: SWOT ANALYSIS

FIGURE 23 DR. REDDY’S LABORATORY: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 24 DR. REDDY’S LABORATORY: SWOT ANALYSIS

FIGURE 25 PFIZER INC.: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 26 PFIZER INC.: SWOT ANALYSIS

FIGURE 27 VIATRIS INC. (MYLAN N.V): FINANCIAL OVERVIEW SNAPSHOT

FIGURE 28 VIATRIS INC. (MYLAN N.V): SWOT ANALYSIS

FIGURE 29 B.BRAUN MELSUNGEN AG: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 30 B.BRAUN MELSUNGEN AG: SWOT ANALYSIS

FIGURE 31 BAXTER INTERNATIONAL INC.: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 32 BAXTER INTERNATIONAL INC.: SWOT ANALYSIS